Literature DB >> 1149281

Glycylprolyl beta-naphthylamidase activity in human serum.

M Hino, T Nagatsu, S Kakumu, S Okuyama, Y Yoshii, I Nagatsu.   

Abstract

Glycylprolyl beta-naphthylamidase activities in sera from 40 normal subjects (18-81 years) were: 22.6 +/- 0.9 (S.E.) (11.8-38.2) I.U./1 serum at 37 degrees C. The enzyme activities did not differ significantly with age between the younger group under 40-years-old and the older group over 40-years-old. Males, especially under 40-years-old, had slight but significantly higher activities than females. The levels were decreased in patients with gastric cancer. The levels were elevated in patients with hepatobiliary diseases, and had significant correlations with the results of the serum tests in hepatic diseases such as glutamic-oxaloacetic transaminase, glutamic-pyruvic transaminase, alkaline phosphatase and total bilirubin, but had no correlation with serum lactate dehydrogenase. In cellulose acetate electrophoresis, normal sera had a single peak at the beta-globulin region, but the sera in hepatitis or liver cirrhosis showed not only an increase in the normal peak at the beta-globulin region but also the appearance of the other one or two new peaks in the alpha1 and alpha2-globulin regions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149281     DOI: 10.1016/0009-8981(75)90273-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  Immunochemical identity of dipeptidyl aminopeptidase IV from pig serum, liver, submaxillary gland and kidney.

Authors:  K M Fukasawa; K Fukasawa; M Harada
Journal:  Experientia       Date:  1979-09-15

2.  Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.

Authors:  L A Frohman; T R Downs; T C Williams; E P Heimer; Y C Pan; A M Felix
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  A new assay of X-prolyl dipeptidyl-aminopeptidase activity in human serum with glycylproline p-phenylazoanilide as substrate.

Authors:  T Kato; K Iwase; T Nagatsu; M Hino; T Takemoto; S Sakakibara
Journal:  Mol Cell Biochem       Date:  1979-03-05       Impact factor: 3.396

4.  Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain.

Authors:  Y Watanabe; T Kojima; Y Fujimoto
Journal:  Experientia       Date:  1987-04-15

5.  Release of bile canalicular membrane antigen into blood in experimental extrahepatic cholestasis of the rat.

Authors:  Y Kobayashi; H Ohta; T Kawasaki; M Matsumoto; K Tamakoshi; K Kanai
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

6.  Purification of dipeptidyl-aminopeptidase IV from human kidney by anti dipeptidyl-aminopeptidase IV affinity chromatography.

Authors:  T Hama; M Okada; K Kojima; T Kato; M Matsuyama; T Nagatsu
Journal:  Mol Cell Biochem       Date:  1982-03-05       Impact factor: 3.396

7.  [Peptidases II. Localization of dipeptidylpeptidase IV (DPP IV). Histochemical and biochemical study].

Authors:  R Gossrau
Journal:  Histochemistry       Date:  1979-04-03

8.  Involvement of dipeptidyl peptidase IV in an in vivo immune response.

Authors:  T Kubota; G R Flentke; W W Bachovchin; B D Stollar
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

9.  Reduction of serum X-prolyl dipeptidyl-aminopeptidase activity in tumour-bearing mice and reversal of reduced enzyme activity by lentinan, an anti-tumour polysaccharide.

Authors:  T Kato; T Nagatsu; T Shiio; S Sakakibara
Journal:  Experientia       Date:  1979-03-15

10.  Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.

Authors:  Arpi Nazarian; Kevin Lawlor; San San Yi; John Philip; Mousumi Ghosh; Mariana Yaneva; Josep Villanueva; Alan Saghatelian; Melissa Assel; Andrew J Vickers; James A Eastham; Howard I Scher; Brett S Carver; Hans Lilja; Paul Tempst
Journal:  Mol Cell Proteomics       Date:  2014-07-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.